nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—Ethylmorphine—POR—urinary bladder cancer	0.0134	0.539	CrCbGaD
Oxycodone—CYP3A4—Thiotepa—urinary bladder cancer	0.0124	0.41	CbGbCtD
Oxycodone—Codeine—UGT2B7—urinary bladder cancer	0.0087	0.35	CrCbGaD
Oxycodone—CYP3A5—Etoposide—urinary bladder cancer	0.00861	0.285	CbGbCtD
Oxycodone—CYP2D6—Doxorubicin—urinary bladder cancer	0.0036	0.119	CbGbCtD
Oxycodone—CYP3A4—Etoposide—urinary bladder cancer	0.00336	0.111	CbGbCtD
Oxycodone—Naloxone—ESR1—urinary bladder cancer	0.00275	0.111	CrCbGaD
Oxycodone—CYP3A4—Doxorubicin—urinary bladder cancer	0.00229	0.0758	CbGbCtD
Oxycodone—Eye disorder—Methotrexate—urinary bladder cancer	0.000479	0.00056	CcSEcCtD
Oxycodone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000479	0.00056	CcSEcCtD
Oxycodone—Tinnitus—Methotrexate—urinary bladder cancer	0.000478	0.000559	CcSEcCtD
Oxycodone—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000478	0.000558	CcSEcCtD
Oxycodone—Asthenia—Cisplatin—urinary bladder cancer	0.000477	0.000556	CcSEcCtD
Oxycodone—Pharyngitis—Epirubicin—urinary bladder cancer	0.000476	0.000556	CcSEcCtD
Oxycodone—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000476	0.000556	CcSEcCtD
Oxycodone—Sweating—Doxorubicin—urinary bladder cancer	0.000474	0.000554	CcSEcCtD
Oxycodone—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000474	0.000554	CcSEcCtD
Oxycodone—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000473	0.000552	CcSEcCtD
Oxycodone—Haematuria—Doxorubicin—urinary bladder cancer	0.000472	0.000551	CcSEcCtD
Oxycodone—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000472	0.000551	CcSEcCtD
Oxycodone—Urethral disorder—Epirubicin—urinary bladder cancer	0.000471	0.00055	CcSEcCtD
Oxycodone—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000468	0.000546	CcSEcCtD
Oxycodone—Epistaxis—Doxorubicin—urinary bladder cancer	0.000467	0.000545	CcSEcCtD
Oxycodone—Angiopathy—Methotrexate—urinary bladder cancer	0.000465	0.000543	CcSEcCtD
Oxycodone—Sinusitis—Doxorubicin—urinary bladder cancer	0.000464	0.000542	CcSEcCtD
Oxycodone—Immune system disorder—Methotrexate—urinary bladder cancer	0.000463	0.000541	CcSEcCtD
Oxycodone—Dizziness—Fluorouracil—urinary bladder cancer	0.000463	0.000541	CcSEcCtD
Oxycodone—Visual impairment—Epirubicin—urinary bladder cancer	0.000463	0.00054	CcSEcCtD
Oxycodone—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000462	0.00054	CcSEcCtD
Oxycodone—Chills—Methotrexate—urinary bladder cancer	0.00046	0.000537	CcSEcCtD
Oxycodone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000454	0.000531	CcSEcCtD
Oxycodone—Vomiting—Gemcitabine—urinary bladder cancer	0.000453	0.000529	CcSEcCtD
Oxycodone—Bradycardia—Doxorubicin—urinary bladder cancer	0.000452	0.000528	CcSEcCtD
Oxycodone—Mental disorder—Methotrexate—urinary bladder cancer	0.000449	0.000525	CcSEcCtD
Oxycodone—Rash—Gemcitabine—urinary bladder cancer	0.000449	0.000525	CcSEcCtD
Oxycodone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000449	0.000524	CcSEcCtD
Oxycodone—Eye disorder—Epirubicin—urinary bladder cancer	0.000449	0.000524	CcSEcCtD
Oxycodone—Hypersensitivity—Etoposide—urinary bladder cancer	0.000448	0.000523	CcSEcCtD
Oxycodone—Tinnitus—Epirubicin—urinary bladder cancer	0.000448	0.000523	CcSEcCtD
Oxycodone—Malnutrition—Methotrexate—urinary bladder cancer	0.000447	0.000521	CcSEcCtD
Oxycodone—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000446	0.000521	CcSEcCtD
Oxycodone—Headache—Gemcitabine—urinary bladder cancer	0.000446	0.000521	CcSEcCtD
Oxycodone—Flushing—Epirubicin—urinary bladder cancer	0.000446	0.00052	CcSEcCtD
Oxycodone—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000446	0.00052	CcSEcCtD
Oxycodone—Vomiting—Fluorouracil—urinary bladder cancer	0.000445	0.00052	CcSEcCtD
Oxycodone—Rhinitis—Doxorubicin—urinary bladder cancer	0.000445	0.00052	CcSEcCtD
Oxycodone—Hepatitis—Doxorubicin—urinary bladder cancer	0.000444	0.000519	CcSEcCtD
Oxycodone—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000444	0.000519	CcSEcCtD
Oxycodone—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000442	0.000516	CcSEcCtD
Oxycodone—Rash—Fluorouracil—urinary bladder cancer	0.000442	0.000516	CcSEcCtD
Oxycodone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000441	0.000515	CcSEcCtD
Oxycodone—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000441	0.000515	CcSEcCtD
Oxycodone—Headache—Fluorouracil—urinary bladder cancer	0.000439	0.000513	CcSEcCtD
Oxycodone—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000439	0.000512	CcSEcCtD
Oxycodone—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000438	0.000511	CcSEcCtD
Oxycodone—Dysgeusia—Methotrexate—urinary bladder cancer	0.000437	0.000511	CcSEcCtD
Oxycodone—Asthenia—Etoposide—urinary bladder cancer	0.000437	0.00051	CcSEcCtD
Oxycodone—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000437	0.00051	CcSEcCtD
Oxycodone—Angiopathy—Epirubicin—urinary bladder cancer	0.000436	0.000509	CcSEcCtD
Oxycodone—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000435	0.000508	CcSEcCtD
Oxycodone—Immune system disorder—Epirubicin—urinary bladder cancer	0.000434	0.000506	CcSEcCtD
Oxycodone—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000433	0.000505	CcSEcCtD
Oxycodone—Back pain—Methotrexate—urinary bladder cancer	0.000432	0.000504	CcSEcCtD
Oxycodone—Chills—Epirubicin—urinary bladder cancer	0.000431	0.000503	CcSEcCtD
Oxycodone—Pruritus—Etoposide—urinary bladder cancer	0.00043	0.000503	CcSEcCtD
Oxycodone—Visual impairment—Doxorubicin—urinary bladder cancer	0.000428	0.0005	CcSEcCtD
Oxycodone—Nausea—Gemcitabine—urinary bladder cancer	0.000423	0.000494	CcSEcCtD
Oxycodone—Vomiting—Cisplatin—urinary bladder cancer	0.000422	0.000493	CcSEcCtD
Oxycodone—Mental disorder—Epirubicin—urinary bladder cancer	0.000421	0.000491	CcSEcCtD
Oxycodone—Rash—Cisplatin—urinary bladder cancer	0.000419	0.000489	CcSEcCtD
Oxycodone—Dermatitis—Cisplatin—urinary bladder cancer	0.000418	0.000489	CcSEcCtD
Oxycodone—Malnutrition—Epirubicin—urinary bladder cancer	0.000418	0.000488	CcSEcCtD
Oxycodone—Diarrhoea—Etoposide—urinary bladder cancer	0.000416	0.000486	CcSEcCtD
Oxycodone—Nausea—Fluorouracil—urinary bladder cancer	0.000416	0.000486	CcSEcCtD
Oxycodone—Eye disorder—Doxorubicin—urinary bladder cancer	0.000415	0.000485	CcSEcCtD
Oxycodone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000414	0.000484	CcSEcCtD
Oxycodone—Tinnitus—Doxorubicin—urinary bladder cancer	0.000414	0.000484	CcSEcCtD
Oxycodone—Anaemia—Methotrexate—urinary bladder cancer	0.000413	0.000482	CcSEcCtD
Oxycodone—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000412	0.000481	CcSEcCtD
Oxycodone—Flushing—Doxorubicin—urinary bladder cancer	0.000412	0.000481	CcSEcCtD
Oxycodone—Flatulence—Epirubicin—urinary bladder cancer	0.000412	0.000481	CcSEcCtD
Oxycodone—Tension—Epirubicin—urinary bladder cancer	0.00041	0.000479	CcSEcCtD
Oxycodone—Dysgeusia—Epirubicin—urinary bladder cancer	0.000409	0.000478	CcSEcCtD
Oxycodone—Nervousness—Epirubicin—urinary bladder cancer	0.000406	0.000474	CcSEcCtD
Oxycodone—Back pain—Epirubicin—urinary bladder cancer	0.000404	0.000472	CcSEcCtD
Oxycodone—Angiopathy—Doxorubicin—urinary bladder cancer	0.000403	0.000471	CcSEcCtD
Oxycodone—Malaise—Methotrexate—urinary bladder cancer	0.000403	0.00047	CcSEcCtD
Oxycodone—Dizziness—Etoposide—urinary bladder cancer	0.000402	0.00047	CcSEcCtD
Oxycodone—Muscle spasms—Epirubicin—urinary bladder cancer	0.000402	0.000469	CcSEcCtD
Oxycodone—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000401	0.000469	CcSEcCtD
Oxycodone—Vertigo—Methotrexate—urinary bladder cancer	0.000401	0.000468	CcSEcCtD
Oxycodone—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.0004	0.000467	CcSEcCtD
Oxycodone—Leukopenia—Methotrexate—urinary bladder cancer	0.0004	0.000467	CcSEcCtD
Oxycodone—Chills—Doxorubicin—urinary bladder cancer	0.000399	0.000465	CcSEcCtD
Oxycodone—Nausea—Cisplatin—urinary bladder cancer	0.000395	0.000461	CcSEcCtD
Oxycodone—Cough—Methotrexate—urinary bladder cancer	0.00039	0.000455	CcSEcCtD
Oxycodone—Mental disorder—Doxorubicin—urinary bladder cancer	0.000389	0.000454	CcSEcCtD
Oxycodone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000388	0.000453	CcSEcCtD
Oxycodone—Convulsion—Methotrexate—urinary bladder cancer	0.000387	0.000452	CcSEcCtD
Oxycodone—Vomiting—Etoposide—urinary bladder cancer	0.000387	0.000452	CcSEcCtD
Oxycodone—Malnutrition—Doxorubicin—urinary bladder cancer	0.000387	0.000452	CcSEcCtD
Oxycodone—Anaemia—Epirubicin—urinary bladder cancer	0.000386	0.000451	CcSEcCtD
Oxycodone—Agitation—Epirubicin—urinary bladder cancer	0.000384	0.000448	CcSEcCtD
Oxycodone—Rash—Etoposide—urinary bladder cancer	0.000384	0.000448	CcSEcCtD
Oxycodone—Dermatitis—Etoposide—urinary bladder cancer	0.000383	0.000448	CcSEcCtD
Oxycodone—Headache—Etoposide—urinary bladder cancer	0.000381	0.000445	CcSEcCtD
Oxycodone—Flatulence—Doxorubicin—urinary bladder cancer	0.000381	0.000445	CcSEcCtD
Oxycodone—Myalgia—Methotrexate—urinary bladder cancer	0.00038	0.000444	CcSEcCtD
Oxycodone—Chest pain—Methotrexate—urinary bladder cancer	0.00038	0.000444	CcSEcCtD
Oxycodone—Arthralgia—Methotrexate—urinary bladder cancer	0.00038	0.000444	CcSEcCtD
Oxycodone—Tension—Doxorubicin—urinary bladder cancer	0.000379	0.000443	CcSEcCtD
Oxycodone—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000379	0.000442	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000378	0.000441	CcSEcCtD
Oxycodone—Malaise—Epirubicin—urinary bladder cancer	0.000377	0.00044	CcSEcCtD
Oxycodone—Discomfort—Methotrexate—urinary bladder cancer	0.000376	0.000439	CcSEcCtD
Oxycodone—Nervousness—Doxorubicin—urinary bladder cancer	0.000376	0.000439	CcSEcCtD
Oxycodone—Vertigo—Epirubicin—urinary bladder cancer	0.000375	0.000438	CcSEcCtD
Oxycodone—Syncope—Epirubicin—urinary bladder cancer	0.000375	0.000438	CcSEcCtD
Oxycodone—Leukopenia—Epirubicin—urinary bladder cancer	0.000374	0.000437	CcSEcCtD
Oxycodone—Back pain—Doxorubicin—urinary bladder cancer	0.000374	0.000437	CcSEcCtD
Oxycodone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000372	0.000434	CcSEcCtD
Oxycodone—Palpitations—Epirubicin—urinary bladder cancer	0.000369	0.000431	CcSEcCtD
Oxycodone—Confusional state—Methotrexate—urinary bladder cancer	0.000367	0.000429	CcSEcCtD
Oxycodone—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000367	0.000429	CcSEcCtD
Oxycodone—Cough—Epirubicin—urinary bladder cancer	0.000365	0.000426	CcSEcCtD
Oxycodone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000364	0.000426	CcSEcCtD
Oxycodone—Convulsion—Epirubicin—urinary bladder cancer	0.000362	0.000423	CcSEcCtD
Oxycodone—Infection—Methotrexate—urinary bladder cancer	0.000362	0.000423	CcSEcCtD
Oxycodone—Nausea—Etoposide—urinary bladder cancer	0.000361	0.000422	CcSEcCtD
Oxycodone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000359	0.000419	CcSEcCtD
Oxycodone—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000357	0.000417	CcSEcCtD
Oxycodone—Anaemia—Doxorubicin—urinary bladder cancer	0.000357	0.000417	CcSEcCtD
Oxycodone—Arthralgia—Epirubicin—urinary bladder cancer	0.000356	0.000415	CcSEcCtD
Oxycodone—Myalgia—Epirubicin—urinary bladder cancer	0.000356	0.000415	CcSEcCtD
Oxycodone—Chest pain—Epirubicin—urinary bladder cancer	0.000356	0.000415	CcSEcCtD
Oxycodone—Agitation—Doxorubicin—urinary bladder cancer	0.000355	0.000415	CcSEcCtD
Oxycodone—Anxiety—Epirubicin—urinary bladder cancer	0.000355	0.000414	CcSEcCtD
Oxycodone—Skin disorder—Methotrexate—urinary bladder cancer	0.000354	0.000413	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000353	0.000413	CcSEcCtD
Oxycodone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000352	0.000411	CcSEcCtD
Oxycodone—Discomfort—Epirubicin—urinary bladder cancer	0.000352	0.00041	CcSEcCtD
Oxycodone—Malaise—Doxorubicin—urinary bladder cancer	0.000349	0.000407	CcSEcCtD
Oxycodone—Dry mouth—Epirubicin—urinary bladder cancer	0.000348	0.000406	CcSEcCtD
Oxycodone—Vertigo—Doxorubicin—urinary bladder cancer	0.000347	0.000406	CcSEcCtD
Oxycodone—Anorexia—Methotrexate—urinary bladder cancer	0.000347	0.000406	CcSEcCtD
Oxycodone—Syncope—Doxorubicin—urinary bladder cancer	0.000347	0.000405	CcSEcCtD
Oxycodone—Leukopenia—Doxorubicin—urinary bladder cancer	0.000346	0.000404	CcSEcCtD
Oxycodone—Confusional state—Epirubicin—urinary bladder cancer	0.000344	0.000402	CcSEcCtD
Oxycodone—Palpitations—Doxorubicin—urinary bladder cancer	0.000342	0.000399	CcSEcCtD
Oxycodone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000341	0.000398	CcSEcCtD
Oxycodone—Oedema—Epirubicin—urinary bladder cancer	0.000341	0.000398	CcSEcCtD
Oxycodone—Hypotension—Methotrexate—urinary bladder cancer	0.000341	0.000398	CcSEcCtD
Oxycodone—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00034	0.000397	CcSEcCtD
Oxycodone—Infection—Epirubicin—urinary bladder cancer	0.000339	0.000396	CcSEcCtD
Oxycodone—Cough—Doxorubicin—urinary bladder cancer	0.000337	0.000394	CcSEcCtD
Oxycodone—Shock—Epirubicin—urinary bladder cancer	0.000336	0.000392	CcSEcCtD
Oxycodone—Convulsion—Doxorubicin—urinary bladder cancer	0.000335	0.000391	CcSEcCtD
Oxycodone—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000334	0.000391	CcSEcCtD
Oxycodone—Tachycardia—Epirubicin—urinary bladder cancer	0.000333	0.000389	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000332	0.000388	CcSEcCtD
Oxycodone—Skin disorder—Epirubicin—urinary bladder cancer	0.000331	0.000387	CcSEcCtD
Oxycodone—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00033	0.000385	CcSEcCtD
Oxycodone—Insomnia—Methotrexate—urinary bladder cancer	0.00033	0.000385	CcSEcCtD
Oxycodone—Arthralgia—Doxorubicin—urinary bladder cancer	0.000329	0.000384	CcSEcCtD
Oxycodone—Chest pain—Doxorubicin—urinary bladder cancer	0.000329	0.000384	CcSEcCtD
Oxycodone—Myalgia—Doxorubicin—urinary bladder cancer	0.000329	0.000384	CcSEcCtD
Oxycodone—Anxiety—Doxorubicin—urinary bladder cancer	0.000328	0.000383	CcSEcCtD
Oxycodone—Paraesthesia—Methotrexate—urinary bladder cancer	0.000327	0.000382	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000327	0.000382	CcSEcCtD
Oxycodone—Discomfort—Doxorubicin—urinary bladder cancer	0.000325	0.00038	CcSEcCtD
Oxycodone—Anorexia—Epirubicin—urinary bladder cancer	0.000325	0.00038	CcSEcCtD
Oxycodone—Dyspnoea—Methotrexate—urinary bladder cancer	0.000325	0.000379	CcSEcCtD
Oxycodone—Somnolence—Methotrexate—urinary bladder cancer	0.000324	0.000378	CcSEcCtD
Oxycodone—Dry mouth—Doxorubicin—urinary bladder cancer	0.000322	0.000376	CcSEcCtD
Oxycodone—Dyspepsia—Methotrexate—urinary bladder cancer	0.000321	0.000375	CcSEcCtD
Oxycodone—Hypotension—Epirubicin—urinary bladder cancer	0.000319	0.000372	CcSEcCtD
Oxycodone—Confusional state—Doxorubicin—urinary bladder cancer	0.000318	0.000372	CcSEcCtD
Oxycodone—Decreased appetite—Methotrexate—urinary bladder cancer	0.000317	0.00037	CcSEcCtD
Oxycodone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000316	0.000369	CcSEcCtD
Oxycodone—Oedema—Doxorubicin—urinary bladder cancer	0.000316	0.000369	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000315	0.000367	CcSEcCtD
Oxycodone—Fatigue—Methotrexate—urinary bladder cancer	0.000314	0.000367	CcSEcCtD
Oxycodone—Infection—Doxorubicin—urinary bladder cancer	0.000314	0.000366	CcSEcCtD
Oxycodone—Pain—Methotrexate—urinary bladder cancer	0.000312	0.000364	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000311	0.000363	CcSEcCtD
Oxycodone—Shock—Doxorubicin—urinary bladder cancer	0.00031	0.000363	CcSEcCtD
Oxycodone—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000309	0.000361	CcSEcCtD
Oxycodone—Insomnia—Epirubicin—urinary bladder cancer	0.000308	0.00036	CcSEcCtD
Oxycodone—Tachycardia—Doxorubicin—urinary bladder cancer	0.000308	0.00036	CcSEcCtD
Oxycodone—Skin disorder—Doxorubicin—urinary bladder cancer	0.000307	0.000358	CcSEcCtD
Oxycodone—Paraesthesia—Epirubicin—urinary bladder cancer	0.000306	0.000358	CcSEcCtD
Oxycodone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000305	0.000356	CcSEcCtD
Oxycodone—Dyspnoea—Epirubicin—urinary bladder cancer	0.000304	0.000355	CcSEcCtD
Oxycodone—Somnolence—Epirubicin—urinary bladder cancer	0.000303	0.000354	CcSEcCtD
Oxycodone—Anorexia—Doxorubicin—urinary bladder cancer	0.000301	0.000351	CcSEcCtD
Oxycodone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.0003	0.000351	CcSEcCtD
Oxycodone—Dyspepsia—Epirubicin—urinary bladder cancer	0.0003	0.000351	CcSEcCtD
Oxycodone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000298	0.000348	CcSEcCtD
Oxycodone—Decreased appetite—Epirubicin—urinary bladder cancer	0.000297	0.000346	CcSEcCtD
Oxycodone—Hypotension—Doxorubicin—urinary bladder cancer	0.000295	0.000344	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000294	0.000344	CcSEcCtD
Oxycodone—Fatigue—Epirubicin—urinary bladder cancer	0.000294	0.000343	CcSEcCtD
Oxycodone—Pain—Epirubicin—urinary bladder cancer	0.000292	0.000341	CcSEcCtD
Oxycodone—Constipation—Epirubicin—urinary bladder cancer	0.000292	0.000341	CcSEcCtD
Oxycodone—Urticaria—Methotrexate—urinary bladder cancer	0.00029	0.000338	CcSEcCtD
Oxycodone—Body temperature increased—Methotrexate—urinary bladder cancer	0.000288	0.000336	CcSEcCtD
Oxycodone—Abdominal pain—Methotrexate—urinary bladder cancer	0.000288	0.000336	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000288	0.000336	CcSEcCtD
Oxycodone—Insomnia—Doxorubicin—urinary bladder cancer	0.000285	0.000333	CcSEcCtD
Oxycodone—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000283	0.000331	CcSEcCtD
Oxycodone—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000281	0.000329	CcSEcCtD
Oxycodone—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000281	0.000328	CcSEcCtD
Oxycodone—Somnolence—Doxorubicin—urinary bladder cancer	0.000281	0.000328	CcSEcCtD
Oxycodone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000279	0.000326	CcSEcCtD
Oxycodone—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000278	0.000324	CcSEcCtD
Oxycodone—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000274	0.00032	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000272	0.000318	CcSEcCtD
Oxycodone—Fatigue—Doxorubicin—urinary bladder cancer	0.000272	0.000318	CcSEcCtD
Oxycodone—Urticaria—Epirubicin—urinary bladder cancer	0.000271	0.000316	CcSEcCtD
Oxycodone—Pain—Doxorubicin—urinary bladder cancer	0.00027	0.000315	CcSEcCtD
Oxycodone—Constipation—Doxorubicin—urinary bladder cancer	0.00027	0.000315	CcSEcCtD
Oxycodone—Body temperature increased—Epirubicin—urinary bladder cancer	0.00027	0.000315	CcSEcCtD
Oxycodone—Abdominal pain—Epirubicin—urinary bladder cancer	0.00027	0.000315	CcSEcCtD
Oxycodone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000269	0.000314	CcSEcCtD
Oxycodone—Asthenia—Methotrexate—urinary bladder cancer	0.000261	0.000305	CcSEcCtD
Oxycodone—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00026	0.000304	CcSEcCtD
Oxycodone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000258	0.000301	CcSEcCtD
Oxycodone—Pruritus—Methotrexate—urinary bladder cancer	0.000258	0.000301	CcSEcCtD
Oxycodone—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	0.000254	0.00287	CbGpPWpGaD
Oxycodone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000251	0.000293	CcSEcCtD
Oxycodone—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000251	0.00283	CbGpPWpGaD
Oxycodone—Urticaria—Doxorubicin—urinary bladder cancer	0.000251	0.000293	CcSEcCtD
Oxycodone—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.00025	0.00282	CbGpPWpGaD
Oxycodone—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000249	0.000291	CcSEcCtD
Oxycodone—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000249	0.000291	CcSEcCtD
Oxycodone—Diarrhoea—Methotrexate—urinary bladder cancer	0.000249	0.000291	CcSEcCtD
Oxycodone—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000246	0.00278	CbGpPWpGaD
Oxycodone—Asthenia—Epirubicin—urinary bladder cancer	0.000245	0.000286	CcSEcCtD
Oxycodone—CYP3A7—Biological oxidations—GSTM1—urinary bladder cancer	0.000244	0.00276	CbGpPWpGaD
Oxycodone—Pruritus—Epirubicin—urinary bladder cancer	0.000241	0.000282	CcSEcCtD
Oxycodone—Dizziness—Methotrexate—urinary bladder cancer	0.000241	0.000281	CcSEcCtD
Oxycodone—CYP3A7—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000241	0.00272	CbGpPWpGaD
Oxycodone—Diarrhoea—Epirubicin—urinary bladder cancer	0.000233	0.000272	CcSEcCtD
Oxycodone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000233	0.000272	CcSEcCtD
Oxycodone—Vomiting—Methotrexate—urinary bladder cancer	0.000232	0.000271	CcSEcCtD
Oxycodone—Rash—Methotrexate—urinary bladder cancer	0.00023	0.000268	CcSEcCtD
Oxycodone—Dermatitis—Methotrexate—urinary bladder cancer	0.00023	0.000268	CcSEcCtD
Oxycodone—Headache—Methotrexate—urinary bladder cancer	0.000228	0.000267	CcSEcCtD
Oxycodone—Asthenia—Doxorubicin—urinary bladder cancer	0.000226	0.000264	CcSEcCtD
Oxycodone—Dizziness—Epirubicin—urinary bladder cancer	0.000226	0.000263	CcSEcCtD
Oxycodone—Pruritus—Doxorubicin—urinary bladder cancer	0.000223	0.000261	CcSEcCtD
Oxycodone—Vomiting—Epirubicin—urinary bladder cancer	0.000217	0.000253	CcSEcCtD
Oxycodone—Nausea—Methotrexate—urinary bladder cancer	0.000216	0.000253	CcSEcCtD
Oxycodone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000216	0.000252	CcSEcCtD
Oxycodone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000215	0.00243	CbGpPWpGaD
Oxycodone—Rash—Epirubicin—urinary bladder cancer	0.000215	0.000251	CcSEcCtD
Oxycodone—Dermatitis—Epirubicin—urinary bladder cancer	0.000215	0.000251	CcSEcCtD
Oxycodone—Headache—Epirubicin—urinary bladder cancer	0.000214	0.00025	CcSEcCtD
Oxycodone—Dizziness—Doxorubicin—urinary bladder cancer	0.000209	0.000244	CcSEcCtD
Oxycodone—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000203	0.0023	CbGpPWpGaD
Oxycodone—Nausea—Epirubicin—urinary bladder cancer	0.000203	0.000237	CcSEcCtD
Oxycodone—Vomiting—Doxorubicin—urinary bladder cancer	0.000201	0.000234	CcSEcCtD
Oxycodone—Rash—Doxorubicin—urinary bladder cancer	0.000199	0.000232	CcSEcCtD
Oxycodone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000199	0.000232	CcSEcCtD
Oxycodone—Headache—Doxorubicin—urinary bladder cancer	0.000198	0.000231	CcSEcCtD
Oxycodone—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000197	0.00223	CbGpPWpGaD
Oxycodone—OPRD1—Peptide ligand-binding receptors—CXCL8—urinary bladder cancer	0.000194	0.00219	CbGpPWpGaD
Oxycodone—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	0.000192	0.00217	CbGpPWpGaD
Oxycodone—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00019	0.00214	CbGpPWpGaD
Oxycodone—Nausea—Doxorubicin—urinary bladder cancer	0.000187	0.000219	CcSEcCtD
Oxycodone—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.000177	0.002	CbGpPWpGaD
Oxycodone—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000174	0.00197	CbGpPWpGaD
Oxycodone—OPRK1—Peptide ligand-binding receptors—CXCL8—urinary bladder cancer	0.00017	0.00192	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000166	0.00188	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000164	0.00185	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—CXCL8—urinary bladder cancer	0.000163	0.00185	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	0.000163	0.00184	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	0.000154	0.00174	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NAT1—urinary bladder cancer	0.000154	0.00174	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—HRAS—urinary bladder cancer	0.000153	0.00173	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HDAC4—urinary bladder cancer	0.000146	0.00166	CbGpPWpGaD
Oxycodone—OPRM1—Peptide ligand-binding receptors—CXCL8—urinary bladder cancer	0.000143	0.00162	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—CXCL8—urinary bladder cancer	0.000143	0.00162	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	0.000141	0.0016	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000137	0.00154	CbGpPWpGaD
Oxycodone—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000135	0.00152	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000133	0.0015	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.00013	0.00147	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000129	0.00146	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HDAC4—urinary bladder cancer	0.000128	0.00145	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	0.000127	0.00144	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000126	0.00142	CbGpPWpGaD
Oxycodone—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000124	0.0014	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GLI1—urinary bladder cancer	0.000123	0.00139	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—CXCL8—urinary bladder cancer	0.000121	0.00137	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	0.00012	0.00136	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	0.000118	0.00133	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	0.000117	0.00132	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.000114	0.00129	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	0.000112	0.00126	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NAT1—urinary bladder cancer	0.000112	0.00126	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HDAC4—urinary bladder cancer	0.000109	0.00123	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GLI1—urinary bladder cancer	0.000108	0.00122	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	0.000102	0.00115	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—CXCL8—urinary bladder cancer	9.89e-05	0.00112	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	9.62e-05	0.00109	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—TYMP—urinary bladder cancer	9.36e-05	0.00106	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	9.19e-05	0.00104	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GLI1—urinary bladder cancer	9.1e-05	0.00103	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	8.94e-05	0.00101	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.81e-05	0.000996	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	8.68e-05	0.000981	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CXCL8—urinary bladder cancer	8.67e-05	0.00098	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NAT2—urinary bladder cancer	8.46e-05	0.000956	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	8.46e-05	0.000956	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RBX1—urinary bladder cancer	8.41e-05	0.000951	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	8.37e-05	0.000946	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	8.21e-05	0.000928	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.1e-05	0.000915	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	7.94e-05	0.000897	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NAT1—urinary bladder cancer	7.94e-05	0.000897	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TSC1—urinary bladder cancer	7.91e-05	0.000894	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—JAG1—urinary bladder cancer	7.53e-05	0.000851	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RBX1—urinary bladder cancer	7.38e-05	0.000834	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CXCL8—urinary bladder cancer	7.33e-05	0.000828	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—RRM2—urinary bladder cancer	7.3e-05	0.000825	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	7.26e-05	0.00082	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TSC1—urinary bladder cancer	6.94e-05	0.000784	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	6.76e-05	0.000764	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ENO2—urinary bladder cancer	6.76e-05	0.000764	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TYMP—urinary bladder cancer	6.76e-05	0.000764	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—JAG1—urinary bladder cancer	6.6e-05	0.000746	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	6.56e-05	0.000741	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	6.54e-05	0.000739	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—RHOA—urinary bladder cancer	6.37e-05	0.000719	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RBX1—urinary bladder cancer	6.23e-05	0.000704	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	6.17e-05	0.000698	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NAT2—urinary bladder cancer	6.12e-05	0.000691	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—S100B—urinary bladder cancer	6.1e-05	0.000689	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	6.02e-05	0.00068	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TSC1—urinary bladder cancer	5.86e-05	0.000662	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—RHOA—urinary bladder cancer	5.78e-05	0.000653	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CXCL8—urinary bladder cancer	5.59e-05	0.000631	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—RHOA—urinary bladder cancer	5.58e-05	0.000631	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—JAG1—urinary bladder cancer	5.58e-05	0.000631	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NCOR1—urinary bladder cancer	5.48e-05	0.000619	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	5.47e-05	0.000619	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NQO1—urinary bladder cancer	5.45e-05	0.000616	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—S100B—urinary bladder cancer	5.35e-05	0.000604	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—IL2—urinary bladder cancer	5.34e-05	0.000603	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—RRM2—urinary bladder cancer	5.28e-05	0.000597	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	5.19e-05	0.000586	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	5.19e-05	0.000586	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CXCL8—urinary bladder cancer	5.07e-05	0.000573	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—RHOA—urinary bladder cancer	5.07e-05	0.000573	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CXCL8—urinary bladder cancer	4.9e-05	0.000554	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ENO2—urinary bladder cancer	4.89e-05	0.000552	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	4.89e-05	0.000552	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL2—urinary bladder cancer	4.85e-05	0.000548	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TERT—urinary bladder cancer	4.83e-05	0.000546	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TYMP—urinary bladder cancer	4.81e-05	0.000543	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NCOR1—urinary bladder cancer	4.81e-05	0.000543	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4.75e-05	0.000536	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	4.74e-05	0.000536	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—RHOA—urinary bladder cancer	4.72e-05	0.000533	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—IL2—urinary bladder cancer	4.68e-05	0.000529	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	4.55e-05	0.000514	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—S100B—urinary bladder cancer	4.52e-05	0.000511	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CXCL8—urinary bladder cancer	4.45e-05	0.000503	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FGFR3—urinary bladder cancer	4.43e-05	0.000501	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NAT2—urinary bladder cancer	4.35e-05	0.000491	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ESR1—urinary bladder cancer	4.31e-05	0.000487	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—RHOA—urinary bladder cancer	4.28e-05	0.000484	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.27e-05	0.000483	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL2—urinary bladder cancer	4.25e-05	0.00048	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TERT—urinary bladder cancer	4.24e-05	0.000479	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—TYMS—urinary bladder cancer	4.23e-05	0.000478	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	4.18e-05	0.000472	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	4.18e-05	0.000472	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCL8—urinary bladder cancer	4.14e-05	0.000468	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NCOR1—urinary bladder cancer	4.06e-05	0.000459	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.04e-05	0.000456	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GPX1—urinary bladder cancer	4e-05	0.000452	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—IL2—urinary bladder cancer	3.96e-05	0.000447	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NQO1—urinary bladder cancer	3.94e-05	0.000445	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.93e-05	0.000444	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	3.93e-05	0.000444	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FGFR3—urinary bladder cancer	3.89e-05	0.000439	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ESR1—urinary bladder cancer	3.78e-05	0.000427	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CREBBP—urinary bladder cancer	3.77e-05	0.000426	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL8—urinary bladder cancer	3.76e-05	0.000425	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—RRM2—urinary bladder cancer	3.75e-05	0.000424	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IGF1—urinary bladder cancer	3.73e-05	0.000421	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—EGFR—urinary bladder cancer	3.71e-05	0.000419	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	3.69e-05	0.000417	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL2—urinary bladder cancer	3.59e-05	0.000406	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TERT—urinary bladder cancer	3.58e-05	0.000405	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—KRAS—urinary bladder cancer	3.5e-05	0.000396	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ENO2—urinary bladder cancer	3.48e-05	0.000393	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	3.48e-05	0.000393	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RHOA—urinary bladder cancer	3.41e-05	0.000386	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	3.37e-05	0.000381	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CREBBP—urinary bladder cancer	3.31e-05	0.000374	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	3.29e-05	0.000371	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGFR3—urinary bladder cancer	3.29e-05	0.000371	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF1—urinary bladder cancer	3.27e-05	0.000369	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—EGFR—urinary bladder cancer	3.25e-05	0.000367	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ESR1—urinary bladder cancer	3.19e-05	0.000361	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ERBB2—urinary bladder cancer	3.16e-05	0.000357	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.14e-05	0.000355	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—KRAS—urinary bladder cancer	3.07e-05	0.000347	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TYMS—urinary bladder cancer	3.06e-05	0.000345	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	3.02e-05	0.000341	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	3.02e-05	0.000341	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL8—urinary bladder cancer	3e-05	0.000339	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARG—urinary bladder cancer	2.99e-05	0.000338	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RHOA—urinary bladder cancer	2.99e-05	0.000338	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HRAS—urinary bladder cancer	2.98e-05	0.000337	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GPX1—urinary bladder cancer	2.89e-05	0.000327	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	2.88e-05	0.000325	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL2—urinary bladder cancer	2.86e-05	0.000324	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.84e-05	0.000321	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	2.84e-05	0.000321	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.8e-05	0.000317	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CREBBP—urinary bladder cancer	2.8e-05	0.000316	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCND1—urinary bladder cancer	2.79e-05	0.000316	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ERBB2—urinary bladder cancer	2.77e-05	0.000313	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF1—urinary bladder cancer	2.76e-05	0.000312	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—EGFR—urinary bladder cancer	2.75e-05	0.000311	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MMP9—urinary bladder cancer	2.71e-05	0.000306	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.7e-05	0.000305	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTEN—urinary bladder cancer	2.7e-05	0.000305	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	2.67e-05	0.000302	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL8—urinary bladder cancer	2.63e-05	0.000297	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HRAS—urinary bladder cancer	2.61e-05	0.000295	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—KRAS—urinary bladder cancer	2.6e-05	0.000293	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EP300—urinary bladder cancer	2.57e-05	0.00029	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RHOA—urinary bladder cancer	2.53e-05	0.000286	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL2—urinary bladder cancer	2.51e-05	0.000284	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SRC—urinary bladder cancer	2.5e-05	0.000282	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.45e-05	0.000277	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCND1—urinary bladder cancer	2.45e-05	0.000277	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP9—urinary bladder cancer	2.38e-05	0.000269	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.37e-05	0.000268	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTEN—urinary bladder cancer	2.36e-05	0.000267	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	2.36e-05	0.000266	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ERBB2—urinary bladder cancer	2.34e-05	0.000265	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.34e-05	0.000264	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.27e-05	0.000257	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.27e-05	0.000257	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EP300—urinary bladder cancer	2.25e-05	0.000255	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MYC—urinary bladder cancer	2.24e-05	0.000253	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL8—urinary bladder cancer	2.22e-05	0.000251	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HRAS—urinary bladder cancer	2.21e-05	0.000249	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.2e-05	0.000249	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SRC—urinary bladder cancer	2.19e-05	0.000248	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGFR—urinary bladder cancer	2.19e-05	0.000248	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.17e-05	0.000246	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARG—urinary bladder cancer	2.16e-05	0.000245	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.15e-05	0.000243	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.15e-05	0.000243	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL2—urinary bladder cancer	2.12e-05	0.00024	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	2.08e-05	0.000235	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KRAS—urinary bladder cancer	2.07e-05	0.000234	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCND1—urinary bladder cancer	2.07e-05	0.000234	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.06e-05	0.000232	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTEN—urinary bladder cancer	2.05e-05	0.000232	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.02e-05	0.000228	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP9—urinary bladder cancer	2.01e-05	0.000227	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	2e-05	0.000226	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTEN—urinary bladder cancer	2e-05	0.000226	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MYC—urinary bladder cancer	1.96e-05	0.000222	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—EP300—urinary bladder cancer	1.96e-05	0.000221	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGFR—urinary bladder cancer	1.92e-05	0.000217	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EP300—urinary bladder cancer	1.91e-05	0.000215	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.9e-05	0.000215	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SRC—urinary bladder cancer	1.85e-05	0.000209	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TP53—urinary bladder cancer	1.84e-05	0.000208	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.83e-05	0.000207	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KRAS—urinary bladder cancer	1.81e-05	0.000205	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HRAS—urinary bladder cancer	1.76e-05	0.000199	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.7e-05	0.000192	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MYC—urinary bladder cancer	1.66e-05	0.000188	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGFR—urinary bladder cancer	1.62e-05	0.000183	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TP53—urinary bladder cancer	1.61e-05	0.000182	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HRAS—urinary bladder cancer	1.54e-05	0.000174	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.54e-05	0.000174	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KRAS—urinary bladder cancer	1.53e-05	0.000173	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.53e-05	0.000173	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.49e-05	0.000168	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.48e-05	0.000167	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.42e-05	0.000161	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.42e-05	0.00016	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.4e-05	0.000159	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.4e-05	0.000159	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TP53—urinary bladder cancer	1.36e-05	0.000154	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.34e-05	0.000152	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.32e-05	0.000149	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HRAS—urinary bladder cancer	1.3e-05	0.000147	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.24e-05	0.00014	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.21e-05	0.000137	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.06e-05	0.000119	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.01e-05	0.000114	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.01e-05	0.000114	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	9.67e-06	0.000109	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	7.92e-06	8.95e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	6.9e-06	7.8e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—EP300—urinary bladder cancer	6.58e-06	7.44e-05	CbGpPWpGaD
